Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|18|2|148-154
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.18, Iss.2, 2018-02, pp. : 148-154
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Rosuvastatin treatment appears to reduce disease activity in patients with ankylosing spondylitis
Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. :
By Toğrol RE Nalbant S Solmazgül E Özyurt M Kaplan M Kiralp MZ Dinçer Ü Şahan B
The Journal of International Medical Research, Vol. 37, Iss. 1, 2009-01 ,pp. :
Etoricoxib and the treatment of ankylosing spondylitis
By Lories Rik J
Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. :
Adalimumab on the map in ankylosing spondylitis
Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. :